Browse by popular tags
abvd ac220 act acute lymphoblastic leukaemia acute myelogenous leukemia (aml) acute myeloid leukaemia ade admire adoptive cellular therapy alemtuzumab all allogeneic allogeneic stem cell transplant amgen aml aml 17 aml 18 pilot angioimmunoblastic lymphoma antiviral therapy arctic aspirin autologous stem cell transplant autologous transplant azacitidine b-cell b-cell chronic lymphocytic leukaemia blood cancers bone marrow bortezomib
NHS Logo
The Clinical research facility is part of the NIHR and is funded by the Department of Health
Phase II single-arm NCRI feasibility study of CHOP in combination with ofatumumab in induction and maintenance of patients with newly diagnosed Richter's Syndrome.
The CHOP-OR trial is intended to discover whether the combination of chemotherapy and ofatumumab improves outcomes compared to chemotherapy alone, and also whether there are any rare side effects of ofatumumab in combination with chemotherapy which we do not know about.